Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.

@article{Adam2011ExecutiveCI,
  title={Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.},
  author={Jos J. Adam and Hanna van Houdt and Bart Scholtissen and Veerle Visser-Vandewalle and Ania Winogrodzka and Annelien A. Duits},
  journal={Neuroscience letters},
  year={2011},
  volume={500 2},
  pages={113-7}
}
Using an anti-cue keypress task, we examined executive control in Parkinson's disease (PD) patients treated with deep brain stimulation (DBS) of the subthalamic nucleus (STN) and dopaminergic medication. Across sessions, we varied stimulation (on, off) and dopaminergic medication (on, off). Reaction time (RT) results of the PD patients and their age-matched controls showed a consistent pattern of RT costs and benefits generated by anti-cues with short and long preparation intervals… CONTINUE READING